Parkinson's Disease Trial, Recruiting (NCT06582212)

Parkinson's Disease Trial, Recruiting NCT06582212 Sponsor: University Hospital, Grenoble Condition: Parkinson's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06582212 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Parkinsons Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are a woman who has not yet gone through menopause
You have been diagnosed with Parkinson's disease (PD) according to a specific standard set of diagnostic guidelines
Your Parkinson's symptoms started at least two years before joining the trial
You are between 18 and 56 years old
You have been on a stable Parkinson's medication routine for at least two months, with no expected changes needed in the next three months
You may or may not be using the contraceptive pill or an intrauterine device (IUD/coil)

Who may not be able to join:

Women who have already gone through menopause and have Parkinson's disease
People who have a health condition that the trial doctor believes would make it unsafe or too difficult to complete the study (for example, dementia or severe depression)
People who are unable to give their own informed consent to take part in the trial

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 14 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Elena MORO, CHU Grenoble Alpes

Phone: 0476769452

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06582212

Sponsor: University Hospital, Grenoble

Phase: Not Applicable

Status: Recruiting

Condition: Parkinson's Disease

Trial contact: 0476769452

More information: https://clinicaltrials.gov/study/NCT06582212

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are a woman who has not yet gone through menopause
You have been diagnosed with Parkinson's disease (PD) according to a specific standard set of diagnostic guidelines
Your Parkinson's symptoms started at least two years before joining the trial
You are between 18 and 56 years old
You have been on a stable Parkinson's medication routine for at least two months, with no expected changes needed in the next three months
You may or may not be using the contraceptive pill or an intrauterine device (IUD/coil)

Who may not be able to join:

Women who have already gone through menopause and have Parkinson's disease
People who have a health condition that the trial doctor believes would make it unsafe or too difficult to complete the study (for example, dementia or severe depression)
People who are unable to give their own informed consent to take part in the trial

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 14 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Hospital, Grenoble

Registry

ClinicalTrials.gov

Start date

12 March 2025

Est. completion

12 March 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Reliability of the MyMovesMatter mobile application

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov